Lin Zhang, MD; PhD

Professor

  • 3038 Citations
  • 23 h-Index
19942019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Lin Zhang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 10 Similar Profiles
Parkinson Disease Medicine & Life Sciences
Tremor Medicine & Life Sciences
Parkinsonian Disorders Medicine & Life Sciences
Ataxia Medicine & Life Sciences
Intellectual Disability Medicine & Life Sciences
Dementia Medicine & Life Sciences
China Medicine & Life Sciences
Executive Function Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1994 2019

  • 3038 Citations
  • 23 h-Index
  • 45 Article
  • 1 Chapter

Clinimetric Properties of the Fragile X-associated Tremor Ataxia Syndrome Rating Scale

Hall, D. A., Stebbins, G. T., Jacquemont, S., Berry-Kravis, E., Goetz, C. G., Hagerman, R. J., Zhang, L. & Leehey, M. A., Jan 1 2019, (Accepted/In press) In : Movement Disorders Clinical Practice.

Research output: Contribution to journalArticle

Movement Disorders
Reproducibility of Results
Statistical Factor Analysis
Outcome Assessment (Health Care)
Clinical Trials

Congnitive deficits and associated ERP N400 abnormalities in FXTAS with parkinsonism

Wang, X. H., Yang, J. C., Soohoo, R., Cotter, D., Yuan, M., Xia, J., Yaqub, S., Doty, J., Niu, Y. Q., Tassone, F., Hagerman, R. J., Zhang, L. & Olichney, J. M., Sep 18 2018, In : Frontiers in Genetics. 9, SEP, 327.

Research output: Contribution to journalArticle

Parkinsonian Disorders
Evoked Potentials
Verbal Learning
Brain
Neurologic Examination
1 Citation (Scopus)
Deep Brain Stimulation
Executive Function
Parkinson Disease
Cognitive Dysfunction
6 Citations (Scopus)
Psychotic Disorders
Antipsychotic Agents
Parkinson Disease
Retrospective Studies
Drug-Related Side Effects and Adverse Reactions
15 Citations (Scopus)

A Placebo-Controlled Trial of AQW051 in Patients With Moderate to Severe Levodopa-Induced Dyskinesia

Trenkwalder, C., Berg, D., Rascol, O., Eggert, K., Ceballos-Baumann, A., Corvol, J. C., Storch, A., Zhang, L., Azulay, J. P., Broussolle, E., Defebvre, L., Geny, C., Gostkowski, M., Stocchi, F., Tranchant, C., Derkinderen, P., Durif, F., Espay, A. J., Feigin, A., Houeto, J. L. & 13 others, Schwarz, J., Di Paolo, T., Feuerbach, D., Hockey, H. U., Jaeger, J., Jakab, A., Johns, D., Linazasoro, G., Maruff, P., Rozenberg, I., Sovago, J., Weiss, M. & Gomez-Mancilla, B., Jul 1 2016, In : Movement Disorders. 31, 7, p. 1049-1054 6 p.

Research output: Contribution to journalArticle

Dyskinesias
Levodopa
Placebos
Parkinson Disease
Nicotinic Receptors